Results 181 to 190 of about 2,829,330 (224)

Management of drug-induced liver injury associated with anti-cancer therapy. [PDF]

Front Physiol
Vincenzi B, Yimin M, Andrade RJ, Morales Castillo M, Akhundova-Unadkat G, Mato JM.   +5 more
europepmc   +1 more source

Research Progress on the Treatment of Related Diseases With <i>Astragalus</i>. [PDF]

Drug Des Devel Ther
Zhang X, Lin B, Wang X, Fanɡ N, Wu L, Wan H, Zhou H.   +6 more
europepmc   +1 more source

TAK-994 mechanistic investigation into drug-induced liver injury. [PDF]

Toxicol Sci
Shinozawa T, Miyamoto K, Baker KS, Faber SC, Flores R, Uetrecht J, von Hehn C, Yukawa T, Tohyama K, Kadali H, von Grotthuss M, Sudo Y, Smith EN, Diogo D, Zhu AZX, Dragan Y, Cebers G, Wagoner MP.   +17 more
europepmc   +1 more source

Drug-Induced Liver Injury Associated With Emerging Cancer Therapies. [PDF]

Liver Int
Chodup P, Samodelov SL, Visentin M, Kullak-Ublick GA.   +3 more
europepmc   +1 more source

Recent Research Advances in Multi-Functional Diallyl Trisulfide (DATS): A Comprehensive Review of Characteristics, Metabolism, Pharmacodynamics, Applications, and Drug Delivery Systems. [PDF]

Int J Nanomedicine
Wang M, Yu J, Xu H, Xu K, Sohail M, Wang J, Ning H, Zhang J, Yu B.   +8 more
europepmc   +1 more source

Ferritinophagy: multifaceted roles and potential therapeutic strategies in liver diseases. [PDF]

Front Cell Dev Biol
Wu K, Zhao W, Hou Z, Zhang W, Qin L, Qiu J, Wang D, Zhuang L, Xue X, Sun D.   +9 more
europepmc   +1 more source

Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver. [PDF]

World J Hepatol
Zhao Y, Li JZ, Liu YG, Zhu YJ, Zhang Y, Zheng WW, Ma L, Li J, Wang CY.   +8 more
europepmc   +1 more source

Transcriptomic and proteomic characterization of cell and protein biomarkers of checkpoint inhibitor-induced liver injury. [PDF]

Cancer Immunol Immunother
Ji C, Kumpf S, Qian J, Federspiel JD, Sheehan M, Capunitan D, Atallah E, Astbury S, Arat S, Oziolor E, Ocana MF, Ramaiah SK, Grove J, Aithal GP, Lanz TA.   +14 more
europepmc   +1 more source

Exploring the Nutraceutical Potential of a Food-Medicine Compound for Metabolic-Associated Fatty Liver Disease via Lipidomics and Network Pharmacology. [PDF]

Foods
Deng Y, Cui J, Jiang Y, Zhang J, Jiang J, Zhang Q, Hu Y.   +6 more
europepmc   +1 more source

Recent advances in the role of polysaccharides in liver diseases: a review. [PDF]

Front Pharmacol
Wang J, Wang H, Yang X, Wang K, Zhang Y.
europepmc   +1 more source